ArticleBMC public health2025
Association of sugar-sweetened, artificially sweetened, and unsweetened tea with all-cause and cause-specific mortality: a prospective cohort study in UK biobank.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Although previous observational studies have revealed a significant relationship between tea consumption and reduced mortality risk, the associations of adding sugar or alternative sweeteners to tea with mortality risks are still largely unknown. This study aimed to evaluate the associations of consumption of unsweetened, sugar-sweetened, and artificially sweetened tea with all-cause and cause-specific mortality. A total of 180,344 participants in the UK Biobank were eligible for this study. Data for dietary consumption of unsweetened, sugar-sweetened, and artificially sweetened tea by a 24-hour dietary assessment tool were acquired. During a median follow-up of 11.7 years, 6809 deaths were recorded. Cox models with cubic splines showed significant associations between unsweetened and sugar-sweetened tea and lower all-cause mortality [HRs (95%CI), 0.78 (0.73-0.83)]. Unsweetened tea consumers also had lower risks for cancer and cardiovascular disease (CVD) mortality with the respective HRs (95%CI) of 0.81 (0.74-0.88) and 0.74 (0.64-0.86). The relationship between artificially sweetened tea and mortality risks was inconclusive. Furthermore, more amounts of sugar or alternative sweeteners added to tea may impact the association with mortality. Our findings highlighted that moderate intake of unsweetened and sugar-sweetened tea was associated with lower mortality risks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.